Your browser doesn't support javascript.
loading
Safety and Efficacy of Nano-Pulse Stimulation Treatment of Non-Genital, Cutaneous Warts (Verrucae).
Nuccitelli, Richard; LaTowsky, Brenda M; Lain, Edward; Munavalli, Girish; Loss, Lesley; Ross, E Victor; Jauregui, Lauren; Knape, William A.
Afiliação
  • Nuccitelli R; Pulse Biosciences, 3957 Point Eden Way, Hayward, California, 94545.
  • LaTowsky BM; Clear Dermatology and Aesthetics Center, 20201N. Scottsdale Healthcare Dr. #260, Scottsdale, Arizona, 85255.
  • Lain E; Sanova Dermatology, 1601 E Pflugerville Pkwy,Bldg 1 Ste 1102, Pflugerville, Texas, 78660.
  • Munavalli G; Dermatology, Laser & Vein Specialists, 1918 Randolph Rd., Charlotte, North Carolina, 28207.
  • Loss L; Dermatology Associates, 100 White Spruce Blvd, Rochester, New York, 14623.
  • Ross EV; Scripps Clinic, 3811 Valley Centre Dr., San Diego, California, 92130.
  • Jauregui L; Pulse Biosciences, 3957 Point Eden Way, Hayward, California, 94545.
  • Knape WA; Pulse Biosciences, 3957 Point Eden Way, Hayward, California, 94545.
Lasers Surg Med ; 53(10): 1301-1306, 2021 12.
Article em En | MEDLINE | ID: mdl-34008877
ABSTRACT
BACKGROUND AND

OBJECTIVES:

This study describes the effects of nano-pulse stimulation (NPS) technology on the common verruca with the objectives of demonstrating efficacy and safety. NPS technology applies nanosecond pulses of non-thermal electrical energy to induce highly localized regulated cell death in the cellular structures of the targeted zone with negligible effects on surrounding non-cellular structures. Previous clinical studies applying NPS to common, benign skin lesions have demonstrated safety and efficacy in clearing seborrheic keratoses and sebaceous hyperplasia. STUDY DESIGN/MATERIALS AND

METHODS:

Sixty-two subjects were enrolled at a total of five sites. One hundred and ninety-five study verrucae up to 10 mm wide were treated with NPS delivered by a console-based handheld applicator (CellFX® System; Pulse Biosciences) and follow-ups occurred every 30 days with the option to retreat at 30, 60, and 90 days. There were 62 untreated controls and 46% of the treated verrucae were recalcitrant.

RESULTS:

Overall, 75.3% (70/93) of the common verrucae, 72.7% (8/11) of the flat verrucae, and 43.8% (14/32) of the plantar verrucae treated with NPS were completely clear by 60 days following the last treatment and did not recur within the 120-day observation period. The majority (54%) of verrucae cleared with a single NPS procedure. The most common treatment site reactions were erythema (50.5%) and eschar formation (23.4%) on Day 30 and on Day 120 mild erythema was present in 14% of the cases and hyperpigmentation in 18.5%. No serious adverse events were reported. A particle counter was used during 11 NPS procedures on verrucae and no significant plume generation was detected during these procedures.

CONCLUSIONS:

NPS is a safe and effective procedure for removing non-genital, cutaneous verrucae. Lasers Surg. Med. © 2021 The Authors. Lasers in Surgery and Medicine published by Wiley Periodicals LLC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Verrugas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Verrugas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article